PFBT
ANIX icon

Parkside Financial Bank & Trust’s Anixa Biosciences ANIX Stock Holding History

Parkside Financial Bank & Trust’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.69K Hold
602
– – ﹤0.01% 2243
2026
Q1 		$1.55K Hold
602
– – ﹤0.01% 2206
2025
Q4 		$1.88K Hold
602
– – ﹤0.01% 2123
2025
Q3 		$1.99K Hold
602
– – ﹤0.01% 2031
2025
Q2 		$1.99K Buy
+602
New +$1.72K ﹤0.01% 2007

Other funds holding ANIX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Parkside Financial Bank & Trust's ANIX Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its Anixa Biosciences (ANIX) position steady in Q2 2026 at 602 shares worth $1.69K. The position accounts for ﹤0.01% of the portfolio, ranked #2243.

Parkside Financial Bank & Trust first reported a position in ANIX in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.99K in Q3 2025. 63 funds tracked by Wall St. Rank hold ANIX as of Q2 2026.

  • Parkside Financial Bank & Trust held 602 shares of Anixa Biosciences worth $1.69K as of Q2 2026.
  • Parkside Financial Bank & Trust left its Anixa Biosciences share count unchanged in Q2 2026.
  • Anixa Biosciences made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2243 holding.
  • Parkside Financial Bank & Trust first reported a position in Anixa Biosciences in Q2 2025 and has held it in 5 quarters since.
  • Parkside Financial Bank & Trust's Anixa Biosciences position peaked at $1.99K in Q3 2025.
  • 63 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.